March 4, 2026 · Form 4 insider transaction
Lanckriet Heikki bought 20,000 shares of Biofrontera Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The option vests in twelve equal monthly installments beginning on April 4, 2026.; Options with different terms are not included.